Create a free QxMD account to take advantage of the features offered by Read like saving your papers and creating collections.

Get Started

COMMENT

JOURNAL ARTICLE

P-TEFb as a target to reactivate latent HIV: two Brds are now in hand

Andrew P Rice

Cell Cycle 2013 February 1, 12 (3): 392-3

Comment on: Boehm D, et al. Cell Cycle 2013; 12(3): In this issue.

Full Text Links

Find Full Text Links for this Article

Discussion

You are not logged in. Sign Up or Log In to join the discussion.

Related Papers

A new BET on the control of HIV latency. Jonathan Karn Cell Cycle 2013 February 15, 12 (4): 545-6

BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism. Daniela Boehm, Vincenzo Calvanese, Roy D Dar, Sifei Xing, Sebastian Schroeder, Laura Martins, Katherine Aull, Pao-Chen Li, Vicente Planelles, James E Bradner, Ming-Ming Zhou, Robert F Siliciano, Leor Weinberger, Eric Verdin, Melanie Ott Cell Cycle 2013 February 1, 12 (3): 452-62

Phosphorylation of CDK9 at Ser175 enhances HIV transcription and is a marker of activated P-TEFb in CD4(+) T lymphocytes. Uri R Mbonye, Giridharan Gokulrangan, Manish Datt, Curtis Dobrowolski, Maxwell Cooper, Mark R Chance, Jonathan Karn PLoS Pathogens 2013, 9 (5): e1003338

Relief of two built-In autoinhibitory mechanisms in P-TEFb is required for assembly of a multicomponent transcription elongation complex at the human immunodeficiency virus type 1 promoter. Y W Fong, Q Zhou Molecular and Cellular Biology 2000, 20 (16): 5897-907

The BET bromodomain inhibitor JQ1 activates HIV latency through antagonizing Brd4 inhibition of Tat-transactivation. Zichong Li, Jia Guo, Yuntao Wu, Qiang Zhou Nucleic Acids Research 2013 January 7, 41 (1): 277-87

An in vitro transcription system that recapitulates equine infectious anemia virus tat-mediated inhibition of human immunodeficiency virus type 1 Tat activity demonstrates a role for positive transcription elongation factor b and associated proteins in the mechanism of Tat activation. C Suñé, A C Goldstrohm, J Peng, D H Price, M A Garcia-Blanco Virology 2000 September 1, 274 (2): 356-66

CDK9 autophosphorylation regulates high-affinity binding of the human immunodeficiency virus type 1 tat-P-TEFb complex to TAR RNA. M E Garber, T P Mayall, E M Suess, J Meisenhelder, N E Thompson, K A Jones Molecular and Cellular Biology 2000, 20 (18): 6958-69

TFIIH inhibits CDK9 phosphorylation during human immunodeficiency virus type 1 transcription. M Zhou, S Nekhai, D C Bharucha, A Kumar, H Ge, D H Price, J M Egly, J N Brady Journal of Biological Chemistry 2001 November 30, 276 (48): 44633-40

Requirement for a kinase-specific chaperone pathway in the production of a Cdk9/cyclin T1 heterodimer responsible for P-TEFb-mediated tat stimulation of HIV-1 transcription. B O'Keeffe, Y Fong, D Chen, S Zhou, Q Zhou Journal of Biological Chemistry 2000 January 7, 275 (1): 279-87

Specific interaction of Tat with the human but not rodent P-TEFb complex mediates the species-specific Tat activation of HIV-1 transcription. D Chen, Y Fong, Q Zhou Proceedings of the National Academy of Sciences of the United States of America 1999 March 16, 96 (6): 2728-33

Make the most of Read.
Download the mobile app.

Want full text access to this paper?

Use Read by QxMD to access full text via your institution or open access sources.

Read also provides personalized recommendations to keep you up to date in your field.

Existing User

New to Read

P-TEFb as a target to reactivate latent HIV: two Brds are now in hand

Discussion

Related Papers

Want full text access to this paper?

Save your favorite articles in one place with a free QxMD account.

Read

Search Tips